GSK logo

ViiV Global Medical Lead - Early Development

GSK
Full-time
Remote friendly (Durham, NC)
United States
Medical Affairs

Want to see how your resume matches up to this job? A free trial of our JobsAI will help! With over 2,000 biopharma executives loving it, we think you will too! Try it now — JobsAI.

Role Summary

ViiV Global Medical Lead - Early Development. Lead the global medical strategy from Phase 2b through launch for a key pipeline asset, aligning scientific, clinical, and commercial objectives across the full lifecycle. Collaborate with Early Development, Commercial, Franchise Medical, and Global Medical Sciences to ensure a seamless transition from Phase 2b to launch.

Responsibilities

  • Lead the global medical strategy from Phase 2b through launch, ensuring seamless alignment of scientific, clinical, and commercial objectives across the full lifecycle.
  • Support the development of Target Medicine Profiles (TMPs) ensuring clinical differentiation, feasibility, and alignment with long-term portfolio ambitions.
  • Shape and optimise Phase 3 designs to deliver on pivotal endpoints that address regulatory expectations, real-world needs, and competitive positioning.
  • Chair the Integrated Evidence Team (IET) and provide medical leadership on the Early Commercialisation Team (ECT), Product Commercialisation Team (PCT), and Medical Development Team (MDT); provide asset leadership in partnership with the Medicines Development Lead (MDL) and Global Commercial Lead (GCL).
  • Drive insight generation and external engagement with investigators, KOLs, community and advocacy groups — translating scientific and behavioural insights into evidence planning, TMP refinement, and launch preparation.
  • Analyse evolving data, scientific trends, and competitor pipeline programs to shape positioning and evidence strategy.
  • Integrate cross-functional medical input across Market Access, Health Outcomes, Epidemiology, Implementation Science, Digital, and Communications for cohesive, compliant global execution.

Qualifications

  • Medical Doctor with specialization, PhD, PharmD or extensive industry expertise in immune/inflammatory diseases or infectious diseases (preferably HIV).
  • Proven track record for high performance delivery in Medical Affairs or R&D environments.
  • Medical Affairs approach to understanding and strategising a disease area through insights into patients, practitioners, and healthcare systems.
  • Ability to manage ambiguity, evaluate benefit/risk, and take accountability for decisions.
  • Curiosity and agility to pivot to new areas, assimilate information rapidly, and identify critical questions for decision-making.
  • Experience in exchanging scientific information with high professional standards and adherence to codes of practice.
  • Proven ability to influence peers and manage team members in a matrix organization.
  • Strong teamwork, relationship-building, and influencing skills across organizations.

Skills

  • Strategic medical leadership across phases of development and launch.
  • External engagement with investigators, KOLs, and patient advocacy groups.
  • Evidence planning, TMP refinement, and launch preparation.
  • Cross-functional collaboration across medical, commercial, access, and outcomes teams.

Education

  • Medical degree required; advanced degree (PhD/ PharmD) preferred.